Table 4 Survival % (1-year/5-year) in age groups of oral and pharyngeal cancers diagnosed in 2012–16
From: Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century
Male | 0–49 | 50–59 | 60–69 | 70–79 | 80–89 |
Oral cavity | |||||
Finland | 86/75 | 82/61 | 82/57 | 73/60 | 72/50 |
Sweden | 95/77 | 89/66 | 80/55 | 77/50 | 60/47 |
Oropharynx | |||||
Finland | 95/80 | 85/68 | 80/60 | 66/41 | 66/41 |
Sweden | 96/91 | 94/78 | 88/67 | 77/52 | 61/36 |
Nasopharynx | |||||
Finland | 93/42 | 93/42 | 71/51 | 71/51 | 71/51 |
Sweden | 92/73 | 100/66 | 97/65 | 91/55 | 91/55 |
Hypopharynx | |||||
Finland | 61/27 | 61/27 | 63/28 | 53/23 | 53/23 |
Sweden | 62/31 | 62/31 | 63/26 | 62/21 | 32/0 |
Female | |||||
Oral cavity | |||||
Finland | 87/77 | 91/78 | 90/75 | 82/69 | 69/54 |
Sweden | 97/88 | 88/68 | 89/69 | 85/64 | 74/47 |
Oropharynx | |||||
Finland | 96/77 | 96/77 | 86/70 | 64/43 | 64/43 |
Sweden | 100/87 | 96/80 | 89/71 | 74/52 | 68/51 |
Nasopharynx | |||||
Finland | 94/88 | 94/88 | 85/73 | 85/73 | 85/73 |
Sweden | 97/90 | 97/90 | 100/85 | 94/46 | 94/46 |